Recently, CanSinoBio (Shanghai) Biotechnology Co., Ltd (hereinafter referred to as "CanSinoBio Shanghai") and AsymBio (hereinafter referred to as "AsymBio") reached a strategic cooperation. (hereinafter referred to as "Kalein Biotech"). The two parties will aim at the cutting-edge technology innovation and industry market demand, and realize innovative collaboration and complementary advantages in the field of plasmid, mRNA, LNP biopharmaceutical macromolecules, and jointly promote the research and development and industrialization of mRNA technology.

As a leading company in the vaccine field, CanSinoBio Shanghai has established an advanced mRNA technology platform in the industry, with independently designed and developed sequence optimization software, which can obtain the key sites affecting the stability and the optimal sequence to effectively improve the expression of antigens, and the CMC process is simple and concise, which can shorten the time of product development and quickly realize the industrialization of scientific research results.

In addition, CanSinoBio has an advanced large-scale modern vaccine industrial base in Shanghai, and has achieved innovative breakthroughs in the research and development of many new vaccine products.

The signing of this strategic cooperation will fully utilize the resource advantages of both parties, continue to expand the space of mutual resource sharing, and open up efficient communication channels. Adhering to the spirit of the strategic cooperation contract between the two parties and highlighting the long-term benefits of high trust and diversified cooperation, we are committed to realizing the aggregation effect of 1+1>2 in terms of cost, management, service, user satisfaction and performance, and will continue to push forward the technological innovation and transformation of results to accelerate the R&D and commercialization of the relevant drugs for the benefit of patients around the world.

https://mp.weixin.qq.com/s?__biz=MzI0Nzc5MDU4OQ==&mid=2247494800&idx=1&sn=38b0b7fdd7f6c8e49a1159baef56a32a&chksm=e9a80202dedf8b142c62bb5d8681906ec6df7d144ed307a5b4ffdfb1a6c8a12976b2fceb068d&mpshare=1&scene=1&srcid=0319BStmVl9BJVnNxuhVS9Hy&sharer_shareinfo=d063a655d3f5b6628819e6445c40d215&sharer_shareinfo_first=d063a655d3f5b6628819e6445c40d215#rd